Invesco S&P Smallcap 600 Pure Growth ETF (RZG)
NYSEARCA: RZG · Real-Time Price · USD
63.23
-0.21 (-0.33%)
At close: Oct 6, 2026, 4:00 PM EDT
63.23
0.00 (0.00%)
After-hours: Oct 6, 2026, 6:30 PM EDT
| Assets | $119.41M |
| Expense Ratio | 0.35% |
| PE Ratio | 15.26 |
| Shares Out | 1.91M |
| Dividend (ttm) | $0.36 |
| Dividend Yield | 0.57% |
| Ex-Dividend Date | Sep 21, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 8.66% |
| Volume | 1,724 |
| Open | 63.74 |
| Previous Close | 63.44 |
| Day's Range | 63.16 - 63.74 |
| 52-Week Low | 50.95 |
| 52-Week High | 73.24 |
| Beta | 1.15 |
| Holdings | 130 |
| Inception Date | Mar 1, 2006 |
About RZG
Fund Home PageThe Invesco S&P Smallcap 600 Pure Growth ETF (RZG) is an exchange-traded fund that is based on the S&P Small Cap 600 Pure Growth index. The fund tracks a growth score-weighted index of US small-cap, pure growth companies. RZG was launched on Mar 1, 2006 and is issued by Invesco.
Asset Class Equity
Category Small Growth
Region North America
Stock Exchange NYSE Arca
Ticker Symbol RZG
ETF Provider Invesco
Index Tracked S&P Small Cap 600 Pure Growth
Top 10 Holdings
18.10% of assets| Name | Symbol | Weight |
|---|---|---|
| ACM Research, Inc. | ACMR | 2.48% |
| Acadian Asset Management Inc. | AAMI | 2.02% |
| Dave Inc. | DAVE | 2.00% |
| Protagonist Therapeutics, Inc. | PTGX | 1.99% |
| DXP Enterprises, Inc. | DXPE | 1.78% |
| The Chefs' Warehouse, Inc. | CHEF | 1.71% |
| Arcutis Biotherapeutics, Inc. | ARQT | 1.60% |
| StoneX Group Inc. | SNEX | 1.54% |
| Powell Industries, Inc. | POWL | 1.54% |
| Solaris Energy Infrastructure, Inc. | SEI | 1.43% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 21, 2026 | $0.11141 | Sep 25, 2026 |
| Jun 22, 2026 | $0.08555 | Jun 26, 2026 |
| Mar 23, 2026 | $0.11358 | Mar 27, 2026 |
| Dec 22, 2025 | $0.04934 | Dec 26, 2025 |
| Sep 22, 2025 | $0.05631 | Sep 26, 2025 |
| Jun 23, 2025 | $0.04741 | Jun 27, 2025 |
Performance
RZG had a total return of 16.18% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.69%.
